Department of Translational Medicine
1361 – 1370 of 8653
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer : Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study
2021) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39(20). p.2294-2303(
- Contribution to journal › Article
-
Mark
Attitude towards hpv vaccination and the intention to get vaccinated among female university students in health schools in jordan
(
- Contribution to journal › Article
- 2020
-
Mark
Intake of individual fatty acids and risk of prostate cancer in the European prospective investigation into cancer and nutrition
(
- Contribution to journal › Article
-
Mark
Social participation in persons with upper limb amputation receiving an esthetic prosthesis
(
- Contribution to journal › Article
-
Mark
No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy : a nation-wide register-based study
(
- Contribution to journal › Article
-
Mark
Confidence in the National Immunization Program among parents in Sweden 2016 – A cross-sectional survey
(
- Contribution to journal › Article
-
Mark
Profiling the Protein Targets of Unmodified Bio-Active Molecules with Drug Affinity Responsive Target Stability and Liquid Chromatography/Tandem Mass Spectrometry
(
- Contribution to journal › Scientific review
-
Mark
European Association of Urology Guidelines Office : How We Ensure Transparent Conflict of Interest Disclosure and Management
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling
(
- Contribution to journal › Article
-
Mark
Introduction of a method to calculate cumulative age- And gender-specific lifetime attributable risk (LAR) of cancer in populations after a large-scale nuclear power plant accident
(
- Contribution to journal › Article